AQR Arbitrage’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

AQR Arbitrage’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-38,200	Closed	-$2.7K	–	1063
2023 Q1	$2.7K	Sell	38,200 -1,800	-5%	-$470	﹤0.01%	1001
2022 Q4	$6.07K	Hold	40,000	–	–	﹤0.01%	1004
2022 Q3	$5K	Hold	40,000	–	–	﹤0.01%	1267
2022 Q2	$6K	Hold	40,000	–	–	﹤0.01%	1329
2022 Q1	$15K	Hold	40,000	–	–	﹤0.01%	1183
2021 Q4	$387K	Hold	40,000	–	–	0.01%	984
2021 Q3	$35K	Buy	+40,000	New	+$52K	﹤0.01%	982

AQR Arbitrage's ORIAW Position: Q2 2023 in Review

AQR Arbitrage sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 38,200 shares — an estimated $2.7K sold.

AQR Arbitrage first reported a position in ORIAW in Q3 2021 and held it in 7 quarters. The position peaked at $387K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

AQR Arbitrage reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
AQR Arbitrage sold 38,200 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $2.7K.
AQR Arbitrage first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 7 quarters.
AQR Arbitrage's Orion Biotech Opportunities Corp. Warrant position peaked at $387K in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on AQR Arbitrage's 13F filing for Q2 2023, filed 14 Aug 2023.